Physician profile
Vu D Phan
NPI 1902023336
$705.17
in general payments reported to CMS, 2019-2025
10 companies · $120 in 2025
The $120 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.57 · 2020: $51.05 · 2021: $42.60 · 2022: $128 · 2024: $329 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $283.29 | 2024 | |
| Inari Medical, INC. | $127.83 | 2022 | |
| Glaxosmithkline, LLC. | $79.08 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.28 | 2024-2025 | Fruzaqla, Alunbrig |
| Bard Peripheral Vascular, INC. | $38.68 | 2025 | Rotarexs 6 F X 135 Cm |
| Allergan, INC. | $34.57 | 2019 | |
| Geron Corporation | $27.32 | 2025 | Rytelo |
| Coherus Oncology, INC. | $24.05 | 2025 | Loqtorzi |
| Exelixis INC. | $18.50 | 2024 | Cabometyx |
| Eisai INC. | $14.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vu Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.